National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings, 2179 [05-630]

Download as PDF Federal Register / Vol. 70, No. 8 / Wednesday, January 12, 2005 / Notices and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Council on Aging. Date: February 1–2, 2005. Closed: February 1, 2005, 3 p.m. to 5 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: National Institutes of Health, Building 31, 9000 Rockville Pike, Conference Room 6, Bethesda, MD 20892. Open: February 2, 2005 8 a.m. to 2 p.m. Agenda: Call to Order, Presentation by NINDS; Task Force on Minority Aging Research Report; Working Group on Program Report; and Program Highlights. Place: National Institutes of Health, Building 31, 9000 Rockville Pike, Conference Room 6, Bethesda, MD 20892. Closed: February 2, 2005, 2 p.m. 2:45 p.m. Agenda: To review and evaluate the Intramural Research Program. Place: National Institutes of Health, Building 31, 9000 Rockville Pike, Conference Room 6, Bethesda, MD 20892. Contact Person: Miriam F. Kelty, PhD, Director, Office of Extramural Affairs, National Institute of Aging, National Institutes of Health, 7201 Wisconsin Avenue, Suite 2C218, Bethesda, MD 20892, (301) 496– 9322. In the interest of security, NIH has instituted stringent procedures for entrance into the building by non-government employees. Persons without a government I.D., will need to show a photo I.D. and signin at the security desk upon entering the building. Information is also available on the Institute’s/Center’s home page: hhtp:// www.nih.gov/nia.naca/, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, aging Research, National Institutes of Health, HHS). Dated: January 6, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–629 Filed 1–11–05; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings VerDate jul<14>2003 17:37 Jan 11, 2005 Jkt 205001 Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Ancillary Studies in Liver Diseases to Ongoing NIDDK Clinical Research Studies. Date: February 7, 2005. Time: 11 a.m. to 12:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Dan E. Matsumoto, PhD, Scientific Review Administrator, Review Branch, DEA, NIDDK, Room 749, 6707 Democracy Boulevard, National Institutes of Health, Bethesda, MD 20892–5452. (301) 594–8894. matsumotod@extra.niddk.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel. Therapies for NIDDK and Pancreatic Islet. Date: February 22, 2005. Time: 8 a.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: Double Tree Rockville and Executive Meeting Center, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: D.G. Patel, PhD, Scientific Review Administrator, Review Branch, DEA, NIDDK, National Institutes of Health, Room 755, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–7682, pateldg@niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS.) BILLING CODE 4140–01–M Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S. C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Dated: January 6, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–630 Filed 1–11–05; 8:45 am] BILLING CODE 4140–01–M PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 2179 DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Agency Information Collection Activities: Proposed Collection; Comment Request In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 concerning opportunity for public comment on proposed collections of information, the Substance Abuse and Mental Health Services Administration will publish periodic summaries of proposed information collection activities. To request more information on the proposed projects or to obtain a copy of the information collection plans, call the SAMHSA Reports Clearance Officer on (240) 276–1243. Comments are invited on: (a) Whether the proposed collections of information are necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Proposed Project: National Outcome Measures for Substance Abuse Prevention—(OMB No. 0930–0230)— Revision The mission of SAMHSA’s Center for Substance Abuse Prevention (CSAP) is to decrease substance use and abuse and related problems among the American public. CSAP accomplishes this through field-testing scientifically defensible programs; disseminating comprehensive, culturally appropriate prevention strategies, policies, and systems; and building capacity in states and community-based providers. Data are collected from CSAP grants and contracts where participant outcomes are assessed. The analysis of these data helps determine whether progress is being made in achieving CSAP’s mission. The primary purpose of this proposed data activity is to promote the use among CSAP grantees and contractors of common National Outcome Measures recommended by CSAP as a result of extensive examination and recommendations, using consistent E:\FR\FM\12JAN1.SGM 12JAN1

Agencies

[Federal Register Volume 70, Number 8 (Wednesday, January 12, 2005)]
[Notices]
[Page 2179]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-630]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institute of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S. C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Ancillary Studies in 
Liver Diseases to Ongoing NIDDK Clinical Research Studies.
    Date: February 7, 2005.
    Time: 11 a.m. to 12:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference 
Call).
    Contact Person: Dan E. Matsumoto, PhD, Scientific Review 
Administrator, Review Branch, DEA, NIDDK, Room 749, 6707 Democracy 
Boulevard, National Institutes of Health, Bethesda, MD 20892-5452. 
(301) 594-8894. matsumotod@extra.niddk.nih.gov.
    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel. Therapies for NIDDK and 
Pancreatic Islet.
    Date: February 22, 2005.
    Time: 8 a.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Double Tree Rockville and Executive Meeting Center, 1750 
Rockville Pike, Rockville, MD 20852.
    Contact Person: D.G. Patel, PhD, Scientific Review 
Administrator, Review Branch, DEA, NIDDK, National Institutes of 
Health, Room 755, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, 
(301) 594-7682, pateldg@niddk.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS.)

    Dated: January 6, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-630 Filed 1-11-05; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.